PT Metro Healthcare Indonesia Tbk (ISX:CARE) FFO


ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
77 GF Score
Price Rp414.00
GF Value Rp364.97
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:CARE
77GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp414.00 is trading 13.4% above its estimated GF Value™ of Rp364.97. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • FFO:
  • GF Value™: Rp364.97 vs. price of Rp414.00 (13.4% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
77GF Score

Get the complete analysis for ISX:CARE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp414.00
Price
Rp364.97
GF Value